06.06.2023 - VANCOUVER, British Columbia, June 06, 2023 (GLOBE NEWSWIRE) - Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the Goldman Sachs 44th Annual Global Healthcare .
BURNABY, British Columbia, April 18, 2023 Xenon Pharmaceuticals Inc. , a neurology-focused biopharmaceutical company, today announced that the company will present at the 22nd Annual Needham. | April 18, 2023